| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2010-07-29 14:38:22 |
| Versijas komentārs | |
| Teksts |
Olaine, July 29, 1010
”Olainfarm” will protect its rights to use trademarks
“MIDOLAT®”
/”МИДОЛАТ®” in
Latvia
It has been almost one year since
“MIDOLAT®”/”МИДОЛАТ®”
are the registered trademarks of Olainfarm in Latvia.
Meldonium produced by “Olainfarm” is becoming well known and
gaining popularity in several countries also under the trade mark
“Vazonat®”.
Olainfarm confirms that
the district court of Riga has assigned temporary means of
protection by seizing and recalling from distribution all
medications of the Olainfarm labelled with textual designations
“MIDOLAT®” un “МИДОЛАТ®”, as well as by prohibiting the use of the
textual trademark
“MIDOLAT®”/”МИДОЛАТ®”
in commercial activities of Olainfarm. Although, so far not a
single unit of „MIDOLAT®”
has been sold in Latvia, Olainfarm intends to protect its trademark
rights.
„The loud attack of JSC “Grindeks” on Olainfarm’s
trademarks of
“MIDOLAT®”/”МИДОЛАТ®”
was full of insults, which is yet another
proof that actions of JSC „Grindeks” are desperation driven.
JSC “Grindeks” would be glad to prohibit everyone to produce
the generic version of Mildronats, including the production of
“MIDOLAT®”/”МИДОЛАТ®”.
Registration of trademarks in the Republic of Latvia is done
by the Patent Office of the Republic of Latvia - a competent
governmental institution, which makes its decisions basing not only
upon applications, but also conducts relevant tests and analyses.
With its outcry, JSC „Grindeks” insults not only
Olainfarm, but also the experts of Patent Office of the Republic of
Latvia who registered the trademark of
“MIDOLAT®”/”МИДОЛАТ®”
in Latvia. JSC „Grindeks” itself was very little
preoccupied with honesty, fair competition and respect for
reputation when choosing the name for its product which had only
one letter difference from that of „Remantadīns”®,
(registered trademark of Olainfarm for 15 years) and using Chinese
made API in the production of it. It must be noted, that
despite all the investments in the trademark of
„Remantadīns” ® , Olainfarm brought up no claims
against JSC „Grindeks”. Obviously that good will of Olainfarm
was mistakenly taken by JSC „Grindeks” for the sign of weakness. We
do respect JSC “Grindeks” and its IP rights, however,
in the conditions of the free competition we will not submit to
their obvious dictate and will protect our right to use our
trademarks of
“MIDOLAT®”/”МИДОЛАТ®”.
Besides, all these activities will cause us
some damages, which, however insignificant, will be fully recovered
from the failed party,” says Salvis Lapins, member of Olainfarm’s
Board.
Olainfarm expresses its disappointment with the fact
that its colleagues from the company that for the present is the
biggest producer of medicines in Latvia by the volume of sales, in
times when its sales have been dropping several quarters in a row,
instead of actively working at new markets and new products are
getting involved in challenging a trademark of
“MIDOLAT®”/”МИДОЛАТ®”
registered nearly one year ago and in using such
inappropriate methods as seizing the inventory.
It must be noted that only a court can declare anyone
guilty. Therefore we have reasons to believe that JSC
„Grindeks” has been disrespectful, by distributing their opinion
about legality of Olainfarm’s activities. This is a clear
attempt to damage the long built reputation of
Olainfarm. However, the intentions of JSC „Grindeks” to
protect its formerly exclusive and successful product, by
prohibiting or preventing any other producer to launch similar
medicine are understandable.
AS „Olainfarm“ is one of the largest companies in
Baltic countries with nearly 40 years of experience in production
of medicines and chemical and pharmaceutical products. The key
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Currently products of “Olainfarm” are being exported to
more than 30 countries worldwide, including the Baltics, Russia,
other CIS, Europe, North America, Asia, and
Australia
Information prepared by
Salvis Lapins
JSC "Olainfarm"
Member of the Board
tel. +371 6 7013717,
Cell: + 371 2 6448873
Fax. + 371 6 7013777
E-mail: slapinsh@olainfarm.lv
,
|
| Pielikumi |
|